Stockreport

TriSalus Reports Q3 2024 Financial Results and Provides Business Update

TriSalus Life Sciences, Inc.  (TLSI) 
PDF – Reported Q3 and nine-month revenues of $7.3 million and $21.2 million respectively, up 42% and 66% year-over-year– Provided 2025 guidance with expectations of over 50% [Read more]